(Q34157174)

31 July 2017

1 reference

title

Treatment of locally advanced head and neck cancer: historical and critical review (English)

1 reference

advanced head and neck cancer

31 July 2017

1 reference

1 reference

1 reference

based on heuristic

inferred from title

head and neck carcinoma

1 reference

Muhyi Al-Sarraf

1

1 reference

31 July 2017

publication date

1 September 2002

1 reference

31 July 2017

1 reference

31 July 2017

volume

9

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

387-399

1 reference

Head and neck cancer: present status and future prospects of adjuvant chemotherapy

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900504

The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900504

Role of taxoids in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900504

Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900504

Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900504

Update on chemoradiotherapy for head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900504

Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900504

Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900504

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900504

Nasopharyngeal carcinoma: treatments and outcomes in the 20th century

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900504

Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900504

A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900504

Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900504

A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900504

Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900504

Phase I study of anti--epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900504

Novel therapeutics for head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900504

Epidermal growth factor receptors as a target for cancer treatment: the emerging role of IMC-C225 in the treatment of lung and head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900504

10.1177/107327480200900504

21 January 2018

Identifiers

DOI

0 references

1 reference